NVO Operating Expenses

Novo Nordisk A/S Common Stock · Operating Expenses

NVO logo

NVO Operating Expenses

Latest reportedkr 123.58B DKK
NVO TTM Operating Expenses · DKK (kr 4.19B → kr 123.58B)
High-resolution chart · PNG

NVO operating expenses history

Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.

Novo Nordisk A/S Common Stock Operating Expenses — Trailing twelve months (TTM) (DKK)
Period endingOperating Expenses (DKK)
123,584,000,000
119,819,000,000
122,618,000,000
126,280,000,000
119,071,000,000
120,361,000,000
117,542,000,000
110,703,000,000
106,627,000,000
97,331,000,000
93,922,000,000
87,582,000,000
83,659,000,000
77,908,000,000
73,697,000,000
69,412,000,000
65,544,000,000
61,454,000,000
58,498,000,000
55,381,000,000
54,031,000,000
52,712,000,000
51,888,000,000
51,659,000,000
50,978,000,000
51,317,000,000
49,450,000,000
48,634,000,000
47,885,000,000
47,001,000,000
46,966,000,000
45,915,000,000
44,679,000,000
44,671,000,000
45,097,000,000
45,300,000,000
46,133,000,000
46,207,000,000
46,165,000,000
45,860,000,000
45,694,000,000
45,495,000,000
42,295,000,000
40,581,000,000
39,870,000,000
38,377,000,000
39,752,000,000
39,267,000,000
38,007,000,000
37,971,000,000
37,939,000,000
37,232,000,000
36,734,000,000
35,936,000,000
35,087,000,000
33,767,000,000
32,942,000,000
32,188,000,000
31,383,000,000
31,161,000,000
31,014,000,000
30,761,000,000
30,205,000,000
28,718,000,000
27,212,000,000
26,129,000,000
25,707,000,000
25,245,128,000
24,543,128,000
23,952,985,000
23,144,985,000
23,661,701,200
23,652,371,200
23,337,848,200
23,133,835,200
21,667,441,000
21,101,671,000
20,550,545,000
20,036,607,000
19,205,706,000
18,589,868,000
17,474,257,000
16,486,992,000
15,458,133,000
14,893,783,000
14,503,419,000
14,020,764,000
15,515,863,000
17,031,842,000
18,567,901,000
20,155,434,000
21,405,688,000
22,774,665,000
23,177,853,000
24,426,535,000
24,247,657,000
24,454,101,000
24,921,297,000
24,247,334,000
19,910,110,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.